Cadence Sues Sandoz Over Generic Ofirmev Plans
Cadence Pharmaceuticals Inc. sued Sandoz Inc. in California federal court Monday over Sandoz's plan to make a generic version of the injectable pain reliever Ofirmev, alleging the generic would infringe patents...To view the full article, register now.
Already a subscriber? Click here to view full article